I. Caramella

Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation

P. L. Poliani, F. Bertagna, S. Grisanti, 2022, Frontiers in Oncology.

Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question

A. Berruti, F. Valcamonico, D. Cosentini, 2022, Endocrine.

Is BMI a reliable prognostic parameter in metastatic prostate cancer patients?

S. Grisanti, A. Berruti, F. Valcamonico, 2021, Prostate Cancer and Prostatic Diseases.

Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients

C. Cappelli, G. Mazziotti, D. Farina, 2023, Current Oncology Reports.

Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis

F. Valcamonico, T. Zanotelli, I. Caramella, 2024, Case Reports in Oncology.